A DOUBLE-BLIND RANDOMIZED CONTROL TRIAL TO COMPARE POSTOPERATIVE ANALGESIA WITH EPIDURAL BUPIVACAINE 0.25% AND ROPIVACAINE 0.2% IN LUMBAR SPINE SURGERY

Background: Postoperative pain after spinal surgery delays mobility and discharge from hospital. Bupivacaine and ropivacaine have similar nerve-blocking effects but differ in their impact on motor function. The study aimed to compare these two drugs for epidural analgesia. Methods: After ethical permission and informed consent, a prospective double blind randomized study was conducted at tertiary care hospital, from June 2022 to January 2024 in ASA Grade I or II patients aged 18 and older undergoing lumbar spine surgery under general anaesthesia. Eighty patients were randomly assigned, 40 in each group, to receive either bupivacaine (0.25%) or ropivacaine (0.2%) via epidural infusion with fentanyl. The patients were evaluated for VAS score, motor blockade at pre decided time points (0, 8, 16, 24, 36, 48 hours) and time taken to perform specific manoeuvres. Both the groups were comparable with respect to demographic data and ASA grading. The vi Results: sual analog scale (VAS) scores were comparable at rest and during coughing between the bupivacaine and ropivacaine groups at 0, 8, and 36 hours, but ropivacaine provided significantly better pain relief at 16 and 24 hours. The VAS scores at mobilization showed no significant differences between Bupivacaine and Ropivacaine at 0, 8 hours. However, Ropivacaine showed better pain relief at 16, 24, 36 and 48hours. The motor block assessment showed no significant differences between Bupivacaine and Ropivacaine at 0, 8, 24 and 36 hours. However, at 16 hours with Ropivacaine showed less motor blockade. Ropivacaine was associated with better functional outcomes in terms of maneuvers like turning, standing in front of the bed, walking, and using the toilet, compared to Bupivacaine. Conclusion: For postoperative pain, ropivacaine was more effective than bupivacaine, providing better VAS scores, less motor blockade, and earlier mobility

Authors

Institutions

Publication Details

Journal
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
Published
2025-02-01
DOI
https://doi.org/10.36106/ijsr/7601559
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A DOUBLE-BLIND RANDOMIZED CONTROL TRIAL TO COMPARE POSTOPERATIVE ANALGESIA WITH EPIDURAL BUPIVACAINE 0.25% AND ROPIVACAINE 0.2% IN LUMBAR SPINE SURGERY

V. Rajesh, Varshali Keniya
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
Anesthesia and Pain Management
article

A DOUBLE-BLIND RANDOMIZED CONTROL TRIAL TO COMPARE POSTOPERATIVE ANALGESIA WITH EPIDURAL BUPIVACAINE 0.25% AND ROPIVACAINE 0.2% IN LUMBAR SPINE SURGERY

V. Rajesh, Varshali Keniya
article en

Abstract

Background: Postoperative pain after spinal surgery delays mobility and discharge from hospital. Bupivacaine and ropivacaine have similar nerve-blocking effects but differ in their impact on motor function. The study aimed to compare these two drugs for epidural analgesia. Methods: After ethical permission and informed consent, a prospective double blind randomized study was conducted at tertiary care hospital, from June 2022 to January 2024 in ASA Grade I or II patients aged 18 and older undergoing lumbar spine surgery under general anaesthesia. Eighty patients were randomly assigned, 40 in each group, to receive either bupivacaine (0.25%) or ropivacaine (0.2%) via epidural infusion with fentanyl. The patients were evaluated for VAS score, motor blockade at pre decided time points (0, 8, 16, 24, 36, 48 hours) and time taken to perform specific manoeuvres. Both the groups were comparable with respect to demographic data and ASA grading. The vi Results: sual analog scale (VAS) scores were comparable at rest and during coughing between the bupivacaine and ropivacaine groups at 0, 8, and 36 hours, but ropivacaine provided significantly better pain relief at 16 and 24 hours. The VAS scores at mobilization showed no significant differences between Bupivacaine and Ropivacaine at 0, 8 hours. However, Ropivacaine showed better pain relief at 16, 24, 36 and 48hours. The motor block assessment showed no significant differences between Bupivacaine and Ropivacaine at 0, 8, 24 and 36 hours. However, at 16 hours with Ropivacaine showed less motor blockade. Ropivacaine was associated with better functional outcomes in terms of maneuvers like turning, standing in front of the bed, walking, and using the toilet, compared to Bupivacaine. Conclusion: For postoperative pain, ropivacaine was more effective than bupivacaine, providing better VAS scores, less motor blockade, and earlier mobility

INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
Bharati Vidyapeeth (Deemed to be University) (IN)
Openalex Percentile: Top 94%
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.